PetIQ Inc (PETQ)
16.53
+0.21
(+1.29%)
USD |
NASDAQ |
Apr 26, 16:00
16.52
-0.01
(-0.06%)
After-Hours: 20:00
PetIQ 1 Year Total Returns (Daily): 43.49% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | 43.49% |
April 25, 2024 | 41.30% |
April 24, 2024 | 40.56% |
April 23, 2024 | 40.32% |
April 22, 2024 | 39.56% |
April 19, 2024 | 43.94% |
April 18, 2024 | 44.68% |
April 17, 2024 | 40.23% |
April 16, 2024 | 38.58% |
April 15, 2024 | 38.41% |
April 12, 2024 | 51.84% |
April 11, 2024 | 55.11% |
April 10, 2024 | 54.75% |
April 09, 2024 | 63.16% |
April 08, 2024 | 63.79% |
April 05, 2024 | 64.64% |
April 04, 2024 | 64.54% |
April 03, 2024 | 66.46% |
April 02, 2024 | 59.44% |
April 01, 2024 | 61.63% |
March 28, 2024 | 51.95% |
March 27, 2024 | 47.05% |
March 26, 2024 | 49.37% |
March 25, 2024 | 46.01% |
March 22, 2024 | 51.74% |
Date | Value |
---|---|
March 21, 2024 | 46.18% |
March 20, 2024 | 47.84% |
March 19, 2024 | 47.09% |
March 18, 2024 | 32.99% |
March 15, 2024 | 35.68% |
March 14, 2024 | 37.85% |
March 13, 2024 | 51.19% |
March 12, 2024 | 48.88% |
March 11, 2024 | 47.62% |
March 08, 2024 | 44.68% |
March 07, 2024 | 45.83% |
March 06, 2024 | 47.76% |
March 05, 2024 | 40.66% |
March 04, 2024 | 42.44% |
March 01, 2024 | 70.63% |
February 29, 2024 | 95.39% |
February 28, 2024 | 96.57% |
February 27, 2024 | 95.91% |
February 26, 2024 | 85.15% |
February 23, 2024 | 78.69% |
February 22, 2024 | 74.19% |
February 21, 2024 | 76.76% |
February 20, 2024 | 83.19% |
February 16, 2024 | 71.27% |
February 15, 2024 | 73.09% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-72.98%
Minimum
Oct 10 2022
228.1%
Maximum
Oct 10 2023
1.63%
Average
-3.62%
Median
Jun 19 2020
1 Year Total Returns (Daily) Benchmarks
Dynavax Technologies Corp | 6.26% |
Pacira BioSciences Inc | -40.25% |
Supernus Pharmaceuticals Inc | -18.18% |
Esperion Therapeutics Inc | 57.02% |
Deciphera Pharmaceuticals Inc | 1.81% |